Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sorrento Therapeutics Inc (NQ: SRNE )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Sorrento Therapeutics Inc

< Previous 1 2 3 4 5 6 7 8 Next >
20 Stocks Moving in Monday's Pre-Market Session
Gainers CF Acquisition Corp. VI (NASDAQ: CFVI) rose 23.6% to $14.75 in pre-market trading on continued strength following the SPACs announcement of a merger with Rumble. Digital... 
Via Benzinga
Market Briefing For Tuesday, Nov. 30
With the Fed-head trying to damper optimism in the morning, a higher high is likely deferred, but if we subsequently get one it might be with VIX below 15, again. 
Via Talk Markets
Topics Stocks
Exposures US Equities
2 Moonshot Biotechs with 10x Potential
This strategy identified LGVN stock a month ago, and now its price has skyrocketed. Here are two more biotechs that could do the same. 
Via InvestorPlace
Market Briefing For Wednesday, Nov. 17 - The EV Edition
Raising expectations is exactly what Wall Street needed, to deny any sort of 'double-top' possibility for S&P. Perhaps that's why Goldman Sachs chose today to increase their target to 5100. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Market Briefing For Wednesday, Aug.25
The stock market holds, pretty impressive ahead of 'virtual Jackson Hole', and it faded late in the day just as we thought likely for the late going. 
Via Talk Markets
Market Briefing For Tuesday, Nov. 9
Optimizing portfolio strategies in this market, is fairly straight-forward, even if it doesn't fit catch-phrase descriptions of overbought vs oversold or valuations in an extended or undervalued way.... 
Via Talk Markets
Market Briefing For Thursday, Nov. 4
Offsetting influences are factors which influence the superficially neutral policies of the Fed. By maintaining 'emergency' near-zero rates after the 'emergency', it's soothing to markets, but actually... 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Market Briefing For Thursday, Oct. 28
Downward revisions of growth by the Atlanta Fed 'reverse' prior expectations, although it's particularly interesting since 'heavier' economic conditions tend to keep the Fed more 'at-bay'; though that... 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Market Briefing For Thursday, Oct. 21
Margin 'compression' is a traditional concern about stock prices, especially in big-cap issues, which depend on ongoing operations more than technology, as is often priced based on forthcoming rather... 
Via Talk Markets
Market Briefing For Wednesday, Oct.13
A complex battle has been outlined on both sides of S&P 4400. So, having forecast the rebounds to that area, we expected no defining structure, quickly answering questions about whether there was more... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Market Briefing For Wednesday, Oct. 6
'Raising the stakes' reasonably describes the backdrop surrounding stocks as well as longer range market prospects, fiscal conditions, geopolitical (most obvious China-Taiwan) threats, Oil prices,... 
Via Talk Markets
Market Briefing For Tuesday, Oct. 5
A bear trend developed under cover of distribution for months during which there was little upside potential, and plenty of downside risk. Bounces, periodically will occur, and we may or may not... 
Via Talk Markets
Dear SRNE Stock Fans, Here’s the Latest Patent News to Watch
Despite some relatively bullish news that came out yesterday, investors in vaccine stocks such as SRNE stock are in sell mode today. 
Via InvestorPlace
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Market Briefing For Wednesday, Sept. 29
Negativity in the market accelerates as the 'obviousness' of primary challenges tends to be inflated (no pun), so as to explain a 'correction process' that persists adhering to the pattern outlined... 
Via Talk Markets
Skip the Bullsh*t! CEO Speak Reveals 2 Reddit Stock Gems
Are Redditors Being Fooled By Corporate Showmanship? “If you can’t dazzle them with brilliance, baffle them with bullsh*t.” — W.C. Fields I’ve long suspected that overly dazzling CEOs make for poor... 
Via InvestorPlace
Market Briefing For Thursday, Sept. 23
Decoupling 'tapering' from rate 'hikes' was the preferred path presumed by probably everybody; and that's what we got. GDP forecasts were lowered by the Fed, which infers lack of 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Market Briefing For Wednesday, Sept. 22
True-to-form - market behavior gave no mixed signals on Tuesday. It was up with a bounce; then dipped, bounced, and faded as it went on-hold ahead of the FOMC meeting. 
Via Talk Markets
3 COVID Stocks That Might Double Soon
Here are three healthcare stocks as nominees for a quick double in 2021. 
Via The Motley Fool
Market Briefing For Wednesday, Sept. 15
In light of today's inflation print; you have a negative real yield for mainstream debt; and that's tying into the distress in China (Evergrande again) showing a possible disruption that could cascade... 
Via Talk Markets
Market Briefing For Tuesday, Sept. 14
Inflation and COVID are tied at the hip in this market and economic scenario. I assessed inflation as 'enduring and not transitory' all along, and where COVID comes into-play is as a 'spoiler' to... 
Via Talk Markets
Market Briefing For Tuesday, Sept. 7
Economists are too worried about what's happening under the hood of the economic engine; when they really should realize all that's needed will be effective treatments and better vaccines to 'fuel' the... 
Via Talk Markets
Market Briefing For Thursday, Sept. 2
Near parabolic uptrends exist for the S&P and the Nasdaq, encouraging bulls, who should know better regarding 'finalized phasing' of runs but there's no assurance of a repeat phase of similar moves... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Market Briefing For Wednesday, Sept. 1
Nuances and ambiguities dominate the market and even geopolitical scene at the moment. We are going to have hotter inflation than the Fed would like, but growth does matter, because we concurrently... 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Market Briefing For Tuesday, Aug. 31
Moderate selling was masked in Monday's market, and it's against a clear backdrop of a stretched market, and even month-end pension sales, related to clients of Goldman Sachs raising 13B. The strength... 
Via Talk Markets
Why Shares of Sorrento Therapeutics Jumped This Week
The clinical-stage biopharmaceutical company published promising news in two separate studies. 
Via The Motley Fool
Sorrento's mRNA COVID-19 Vaccine Shows Efficacy In Preclinical Study
Sorrento Therapeutics Inc (NASDAQ: SRNE) has announced preclinical results for its mRNA-based COVID-19 vaccine against SARS-CoV-2. STI-mRNA includes a proprietary designer Spike... 
Via Benzinga
Exposures COVID-19
Market Briefing For Thursday, Aug. 26
Underperformance by many stocks, but few that are really in trouble, is reflective of rising complacency, while technicians are frustrated at the lack of breakouts or breakdowns. That's actually fine,... 
Via Talk Markets
Sorrento In-Licenses COVID-19 Targeted MPro Inhibitors
Sorrento Therapeutics Inc (NASDAQ: SRNE) has entered into an option agreement with The Texas A&M University System for exclusive rights to highly... 
Via Benzinga
Exposures COVID-19
Vaccine Victory
Monday the US stock market moved into further robust mode fueled by official FDA approval of the Pfizer and BioNTech COVID-19 vaccines. Will the momentum last through to Thursday when the Fed's Jackson... 
Via Talk Markets
Topics Economy
Exposures COVID-19 Interest Rates Product Safety
Market Briefing For Tuesday, Aug. 24
Suspended elevation of the S&P may be in-absence of any alternatives to do so, given what pretty much would be a 'snapping' of the short-term uptrend if that's broken. 
Via Talk Markets
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.